Joel Greenblatt’s Bionano Genomics BNGO Stock Holding History

Joel Greenblatt’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19	Closed	-$83K	–	1028
2021 Q2	$83K	Buy	+19	New	+$75K	﹤0.01%	976

Other funds holding BNGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Joel Greenblatt's BNGO Position: Q3 2021 in Review

Joel Greenblatt sold out of Bionano Genomics (BNGO) in Q3 2021, closing a stake of 19 shares — an estimated $83K sold.

Joel Greenblatt first reported a position in BNGO in Q2 2021 and held it in 1 quarter. The position peaked at $83K in Q2 2021. 147 funds tracked by Wall St. Rank hold BNGO as of Q3 2021.

Joel Greenblatt reported no remaining Bionano Genomics position as of Q3 2021 after selling out during the quarter.
Joel Greenblatt sold 19 Bionano Genomics shares in Q3 2021, an estimated $83K.
Joel Greenblatt first reported a position in Bionano Genomics in Q2 2021 and held it in 1 quarter.
Joel Greenblatt's Bionano Genomics position peaked at $83K in Q2 2021.
147 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2021.

Based on Gotham Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.